全文获取类型
收费全文 | 6992篇 |
免费 | 802篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 88篇 |
儿科学 | 237篇 |
妇产科学 | 183篇 |
基础医学 | 828篇 |
口腔科学 | 214篇 |
临床医学 | 694篇 |
内科学 | 1520篇 |
皮肤病学 | 197篇 |
神经病学 | 385篇 |
特种医学 | 479篇 |
外科学 | 1071篇 |
综合类 | 234篇 |
一般理论 | 4篇 |
预防医学 | 612篇 |
眼科学 | 152篇 |
药学 | 368篇 |
中国医学 | 2篇 |
肿瘤学 | 556篇 |
出版年
2021年 | 80篇 |
2019年 | 91篇 |
2018年 | 77篇 |
2017年 | 66篇 |
2016年 | 74篇 |
2015年 | 101篇 |
2014年 | 149篇 |
2013年 | 207篇 |
2012年 | 280篇 |
2011年 | 256篇 |
2010年 | 191篇 |
2009年 | 171篇 |
2008年 | 255篇 |
2007年 | 281篇 |
2006年 | 265篇 |
2005年 | 295篇 |
2004年 | 268篇 |
2003年 | 278篇 |
2002年 | 220篇 |
2001年 | 182篇 |
2000年 | 191篇 |
1999年 | 183篇 |
1998年 | 144篇 |
1997年 | 147篇 |
1996年 | 152篇 |
1995年 | 119篇 |
1994年 | 99篇 |
1993年 | 104篇 |
1992年 | 167篇 |
1991年 | 134篇 |
1990年 | 133篇 |
1989年 | 145篇 |
1988年 | 169篇 |
1987年 | 122篇 |
1986年 | 120篇 |
1985年 | 111篇 |
1984年 | 93篇 |
1983年 | 118篇 |
1982年 | 97篇 |
1981年 | 74篇 |
1980年 | 86篇 |
1979年 | 88篇 |
1978年 | 76篇 |
1977年 | 79篇 |
1976年 | 97篇 |
1975年 | 77篇 |
1974年 | 64篇 |
1973年 | 66篇 |
1971年 | 70篇 |
1970年 | 57篇 |
排序方式: 共有7824条查询结果,搜索用时 15 毫秒
21.
22.
Surgical treatment of lymph nodes with metastatic melanoma from unknown primary site 总被引:1,自引:0,他引:1
To determine the prognosis of patients with lymph node metastases from an unknown primary melanoma, we retrospectively reviewed the clinicopathologic features of 188 such patients treated from 1971 through 1986 and compared their records with those of patients with clinical stage II melanoma with known primary lesions. Patients with lymph node metastases from an unknown primary melanoma represented 4.6% of all patients with melanoma treated during that period. The five- and ten-year survival rates were 42% and 40%, respectively (median, 37 months). When stratified by number of tumor-containing lymph nodes, there was no significant difference in survival between patients with an unknown primary melanoma and lymph node metastases and those with clinical stage II melanoma and known primary sites. The prognosis of the former patients is no worse than that of patients with lymph node metastases from a known primary site and should be treated in a comparable manner. 相似文献
23.
24.
25.
We used immunohistochemistry to evaluate four cytologically malignant cutaneous neoplasms on the face or neck of elderly individuals. All four lesions were composed of a dermal proliferation of spindle and pleomorphic giant cells. Differential diagnosis included spindle cell carcinoma, atypical fibroxanthoma, malignant melanoma, leiomyosarcoma, and angiosarcoma. All four neoplasms were strongly immunoreactive for vimentin and negative for cytokeratin, S100 protein, desmin, and factor-VIII-related antigen. Focal immunoreactivity for lysozyme and/or a1-antichymotrypsin was seen in the giant cells of each lesion. These results supported the diagnosis of atypical fibroxanthoma in each instance. Immunohistochemical staining can provide useful information for distinguishing among malignant cutaneous spindle cell tumors. 相似文献
26.
27.
Ten thrombocytopenic patients (platelets < 10–24 × 10(9)/L) who were refractory to platelet transfusion were investigated for their responsiveness to staphylococcal protein A column therapy. Nine patients had previously been treated with steroids, intravenous immune globulin, and/or other forms of immunosuppressive therapy without improvement in their transfusion response. All patients were receiving multiple platelet transfusions without achieving 1-hour corrected count increments (CCIs) > or = 7500. Eight patients had antibodies that reacted with platelets and were directed against HLA class I antigens, ABO antigens, and/or platelet-specific alloantigens. Plasma (500-2000 mL) from each patient was passed over a protein A silica gel column and then returned to the patient. Patients received from 1 to 14 treatments. A positive response to protein A therapy was defined as at least a doubling of the pretreatment platelet count and/or two successive 10- to 120-minute posttransfusion CCIs > or = 7500. Following plasma treatments, 6 of 10 patients responded with daily platelet counts that averaged 48 +/− 11 × 10(9) per L as compared with counts of 16 +/− 7 × 10(9) per L (p < 0.0005) before treatment. Posttransfusion CCI values determined in four of these patients averaged 2480 +/− 810 and 10,010 +/− 3540 (p < 0.005) before and after treatment, respectively. In contrast, among the four unresponsive patients, platelet counts averaged 10 +/− 9 and 13 +/− 10 × 10(9) per L (p = NS), respectively, while posttransfusion CCIs were 700 +/− 1410 and 1520 +/− 2460 (p = NS), respectively.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
28.
29.
A retrospective review of 23 patients with osteoblastoma was undertaken in an attempt to answer questions concerning the aggressiveness and potential malignancy of this tumour. Demographic information confirmed that recorded in the literature. There was no suggestion of malignant potential, but, significantly, one tumour persisted, with local recurrence after 11 operations over a period of 27 years. A second tumour, a spinal lesion, occurred (still in a benign form) after a symptom-free period of 17 years. Recognition of aggressive features clinically, radiologically and histologically suggests the need for more aggressive surgical treatment, and late recurrence indicates the need for a more guarded prognosis and longer follow-up. 相似文献
30.
A study of 100 high risk lupus pregnancies. 总被引:2,自引:0,他引:2
N M Buchanan M A Khamashta K E Morton S Kerslake E A Baguley G R Hughes 《American journal of reproductive immunology (New York, N.Y. : 1989)》1992,28(3-4):192-194
Certain subgroups of lupus patients and those with circulating antiphospholipid antibodies (aPL) in particular, suffer a high rate of fetal loss. Over the past 4 years, we have prospectively studied 100 pregnancies in patients with systemic lupus erythematosus (SLE) and primary antiphospholipid syndrome. In addition to conventional methods of monitoring SLE and fetal development, we have also used Doppler flow assessment of placental perfusion from the 14th wk of pregnancy onward. Patients with the antiphospholipid syndrome and previous history of thrombotic events were treated with daily heparin (10,000 IU) and low-dose aspirin (75 mg). Those without a history of thrombosis were treated with low-dose prednisolone, azathioprine, or hydroxychloroquine. Pregnancy loss was reduced from 81.3% in 101 previous pregnancies to 36.8% in 100 pregnancies managed by us. None of the patients who received hydroxychloroquine throughout the pregnancy presented fetal malformations. Careful management and close monitoring of the lupus pregnancy has substantially improved fetal outcome. 相似文献